roxadustat - dofaq.co
Tennisster Halep (31) 'geschokt' door vierjarige schorsing, gaat in beroep bij CAS
NOS - 13 Sep 2023
Tennisster Halep (31) 'geschokt' door vierjarige schorsing, gaat in beroep bij CAS ...
Geschorste tennisster Simona Halep eist schadevergoeding van 10 miljoen euro na positieve dopingtest
Het Nieuwsblad - 17 Feb 2024
Geschorste tennisster Simona Halep eist schadevergoeding van 10 miljoen euro na positieve dopingtest ...
Tennis | Wat is Roxadustat, de stof waarop Simona Halep positief is getest?
Eurosport NL - 21 Oct 2022
Tennis | Wat is Roxadustat, de stof waarop Simona Halep positief is getest? ...
Geschorste tennisster Halep rekent op snelle rentree
www.welingelichtekringen.nl - 09 Feb 2024
Geschorste tennisster Halep rekent op snelle rentree ...
Ex-nummer één van de wereld Simona Halep krijgt zware schorsing voor dopinggebruik: “Ik ben geschokt en ...
Het Nieuwsblad - 12 Sep 2023
Ex-nummer één van de wereld Simona Halep krijgt zware schorsing voor dopinggebruik: “Ik ben geschokt en ... ...
Ex-nummer 1 Halep ontkent vals te hebben gespeeld: 'Ooit komt de waarheid aan het licht'
De Standaard - 22 Oct 2022
Ex-nummer 1 Halep ontkent vals te hebben gespeeld: 'Ooit komt de waarheid aan het licht' ...
Simona Halep zegt dat positieve dopingtest te wijten is aan besmet voedingssupplement
Het Nieuwsblad - 27 Apr 2023
Simona Halep zegt dat positieve dopingtest te wijten is aan besmet voedingssupplement ...
A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia | Scientific ...
Nature - 01 Apr 2024
A nomogram for predicting the risk of treatment failure of roxadustat in peritoneal dialysis with renal anemia | Scientific ... ...
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure
Fierce Pharma - 27 Feb 2024
AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure ...
Roxadustat Misses Mark as Anemia Treatment in Transfusion-Dependent, Lower-risk MDS
OncLive - 05 May 2023
Roxadustat Misses Mark as Anemia Treatment in Transfusion-Dependent, Lower-risk MDS ...
Roxadustat: Battle against doping faces new foe | Daily Sabah
Daily Sabah - 21 Jul 2023
Roxadustat: Battle against doping faces new foe | Daily Sabah ...
FDA declines to approve FibroGen's roxadustat for anaemia of CKD
Pharmaceutical Technology - 29 Nov 2022
FDA declines to approve FibroGen's roxadustat for anaemia of CKD ...
Roxadustat Linked to Improved Iron Metabolism vs ESAs in Peritoneal Dialysis
HCPLive - 28 Nov 2023
Roxadustat Linked to Improved Iron Metabolism vs ESAs in Peritoneal Dialysis ...
AstraZeneca Returns to FibroGen the Rights to Roxadustat in US, Other Territories
BioSpace - 28 Feb 2024
AstraZeneca Returns to FibroGen the Rights to Roxadustat in US, Other Territories ...
Esterification promotes the intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend ...
ScienceDirect.com - 31 Jan 2022
Esterification promotes the intracellular accumulation of roxadustat , an activator of hypoxia-inducible factors, to extend ... ...
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by ...
Nature - 08 Oct 2022
HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by ... ...
Chinese Phase 3 Trial of Roxadustat in Non-Myeloid Malignancies Meets Primary End Point
OncLive - 18 May 2023
Chinese Phase 3 Trial of Roxadustat in Non-Myeloid Malignancies Meets Primary End Point ...
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting
Fierce Pharma - 10 Nov 2021
AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting ...
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis ...
Nature - 18 Sep 2023
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis ... ...